ZA200402989B - Stents. - Google Patents

Stents. Download PDF

Info

Publication number
ZA200402989B
ZA200402989B ZA200402989A ZA200402989A ZA200402989B ZA 200402989 B ZA200402989 B ZA 200402989B ZA 200402989 A ZA200402989 A ZA 200402989A ZA 200402989 A ZA200402989 A ZA 200402989A ZA 200402989 B ZA200402989 B ZA 200402989B
Authority
ZA
South Africa
Prior art keywords
stents
formula
compounds
radical
stent
Prior art date
Application number
ZA200402989A
Other languages
English (en)
Inventor
Elisabeth Perzborn
Jochen Kalbe
Wolfram Ledwoch
Didier Meulien
Original Assignee
Bayer Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare Ag filed Critical Bayer Healthcare Ag
Publication of ZA200402989B publication Critical patent/ZA200402989B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L33/00Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
    • A61L33/04Use of organic materials, e.g. acetylsalicylic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16Biologically active materials, e.g. therapeutic substances
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L33/00Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Surgery (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Vascular Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Materials Engineering (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA200402989A 2001-10-24 2004-04-20 Stents. ZA200402989B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10152460A DE10152460A1 (de) 2001-10-24 2001-10-24 Stents

Publications (1)

Publication Number Publication Date
ZA200402989B true ZA200402989B (en) 2005-04-20

Family

ID=7703557

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200402989A ZA200402989B (en) 2001-10-24 2004-04-20 Stents.

Country Status (22)

Country Link
US (1) US20050064006A1 (hr)
EP (1) EP1439869A1 (hr)
JP (1) JP2005506151A (hr)
KR (1) KR20040074977A (hr)
CN (1) CN1575189A (hr)
AU (1) AU2002340549B2 (hr)
BR (1) BR0213481A (hr)
CA (1) CA2464290A1 (hr)
DE (1) DE10152460A1 (hr)
EC (1) ECSP045075A (hr)
EE (1) EE200400080A (hr)
HR (1) HRP20040456A2 (hr)
HU (1) HUP0401760A3 (hr)
IL (1) IL161445A0 (hr)
MA (1) MA26341A1 (hr)
MX (1) MXPA04003755A (hr)
NO (1) NO20041984L (hr)
NZ (1) NZ532443A (hr)
PL (1) PL367968A1 (hr)
RU (1) RU2004115757A (hr)
WO (1) WO2003035133A1 (hr)
ZA (1) ZA200402989B (hr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19962924A1 (de) * 1999-12-24 2001-07-05 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung
DE10129725A1 (de) * 2001-06-20 2003-01-02 Bayer Ag Kombinationstherapie substituierter Oxazolidinone
DE10300111A1 (de) * 2003-01-07 2004-07-15 Bayer Healthcare Ag Verfahren zur Herstellung von 5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid
DE10355461A1 (de) * 2003-11-27 2005-06-23 Bayer Healthcare Ag Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung
DE102004062475A1 (de) * 2004-12-24 2006-07-06 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung
EP1685841A1 (en) * 2005-01-31 2006-08-02 Bayer Health Care Aktiengesellschaft Prevention and treatment of thromboembolic disorders
DE102005045518A1 (de) * 2005-09-23 2007-03-29 Bayer Healthcare Ag 2-Aminoethoxyessigsäure-Derivate und ihre Verwendung
DE102005047558A1 (de) * 2005-10-04 2008-02-07 Bayer Healthcare Ag Kombinationstherapie substituierter Oxazolidinone zur Prophylaxe und Behandlung von cerebralen Durchblutungsstörungen
DE102005047561A1 (de) 2005-10-04 2007-04-05 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung
CA2624310C (en) 2005-10-04 2014-01-07 Bayer Healthcare Ag Polymorphic form of 5-chloro-n-({5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophenecarboxamide
US20070097252A1 (en) * 2005-10-31 2007-05-03 Silverstein D A Imaging methods, cameras, projectors, and articles of manufacture
DE102006034916A1 (de) * 2006-07-28 2008-01-31 Bayer Healthcare Ag Beschichtung künstlicher Oberflächen von medizinischen Hilfsmitteln und Geräten sowie Reinigung und/oder Vorbehandlung von Kathetern und anderen medizinischen Hilfsmitteln und Geräten
DE102006051625A1 (de) * 2006-11-02 2008-05-08 Bayer Materialscience Ag Kombinationstherapie substituierter Oxazolidinone
US8741890B2 (en) * 2007-11-15 2014-06-03 Boehringer Ingelheim International Gmbh Substituted amides, manufacturing and use thereof as medicaments
US11654036B2 (en) 2020-05-26 2023-05-23 Elixir Medical Corporation Anticoagulant compounds and methods and devices for their use

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0623615B1 (de) * 1993-05-01 1999-06-30 MERCK PATENT GmbH Substituierte 1-Phenyl-oxazolidin-2-on Derivate, deren Herstellung und deren Verwendung als Adhäsionsrezeptor-Antagonisten
WO1998046628A1 (en) * 1997-04-14 1998-10-22 Cor Therapeutics, Inc. SELECTIVE FACTOR Xa INHIBITORS
US6273913B1 (en) * 1997-04-18 2001-08-14 Cordis Corporation Modified stent useful for delivery of drugs along stent strut
US20010029351A1 (en) * 1998-04-16 2001-10-11 Robert Falotico Drug combinations and delivery devices for the prevention and treatment of vascular disease
DE19962924A1 (de) * 1999-12-24 2001-07-05 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung
DE10105989A1 (de) * 2001-02-09 2002-08-14 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung

Also Published As

Publication number Publication date
HUP0401760A2 (hu) 2004-12-28
PL367968A1 (en) 2005-03-07
WO2003035133A1 (de) 2003-05-01
EE200400080A (et) 2004-08-16
MXPA04003755A (es) 2004-07-23
MA26341A1 (fr) 2004-10-01
IL161445A0 (en) 2004-09-27
AU2002340549B2 (en) 2007-11-29
EP1439869A1 (de) 2004-07-28
KR20040074977A (ko) 2004-08-26
NO20041984L (no) 2004-05-13
ECSP045075A (es) 2004-05-28
CA2464290A1 (en) 2003-05-01
US20050064006A1 (en) 2005-03-24
BR0213481A (pt) 2004-11-03
JP2005506151A (ja) 2005-03-03
RU2004115757A (ru) 2005-04-10
DE10152460A1 (de) 2003-05-08
HRP20040456A2 (en) 2005-06-30
NZ532443A (en) 2005-11-25
CN1575189A (zh) 2005-02-02
HUP0401760A3 (en) 2008-04-28

Similar Documents

Publication Publication Date Title
JP4549059B2 (ja) 再狭窄を防止するためのステントのコーテイング
US7799335B2 (en) Differential delivery of nitric oxide
AU2002340549B2 (en) Stents
EP1808167B1 (en) Drug-eluting articles with improved drug release profiles
CN101795719B (zh) 药物缓释性支架
US20050043788A1 (en) Drug-eluting stent
JP2001190687A (ja) ステント及びステントグラフト
AU2003283399B2 (en) Drug delivery system
US20080199506A1 (en) Coating of the Entire Surface of Endoprostheses
MXPA04008361A (es) Stents recubiertos con n-{5 -[4-(4- metil-piperazino- metil)- benozilamido]- 2-metilfenil} -4-(3- piridil) -2- pirimidin- amina.
CA2559756A1 (en) Vegf receptor tyrosine kinase inhibitor coated stent
US20050175667A1 (en) Use of endothelin antagonists to prevent restenosis
WO2014125465A2 (en) Method for loading dilatable catherer balloons and dilatation catheters obtained therefrom
JP2009524501A (ja) 水溶性薬剤の放出遅延用薬剤送達システム
JP2007508039A (ja) 生体適合性および生物学的安定性を有する医療用品表面コーティング
AU2011329270B2 (en) Local vascular delivery of an adenosine A2A receptor agonist / phosphodiesterase inhibitor combination to reduce myocardial injury
CA2453977A1 (en) Stents with vitronectin receptor antagonists against restenosis
PL236142B1 (pl) Sposób wytwarzania z układu kopolimer-inhibitor szlaku mTOR powłoki o kontrolowanej kinetyce uwalniania inhibitora szlaku mTOR na polimerowych stentach naczyniowych